Medical Weight Loss with GLP-1 is primarily used to treat obesity and conditions related to weight gain
After treated with test compounds for 15 hours, harvested in 5 ml Dulbecco s modified medium containing Deep Red Reagent (5 M) (Molecular Probes, Invitrogen) and incubated for 30 min at 37C in a tissue culture incubator
Lancet Neurol 14(3):329340 Biessels GJ, Verhagen C, Janssen J et al (2019) Effect of linagliptin on cognitive performance in patients with type 2 diabetes and cardiorenal comorbidities: the CARMELINA randomized trial
VrintsCAndreottiFKoskinasKCRosselloXAdamoMAinslieJet al2024 ESC guidelines for the management of chronic coronary syndromes
Consistent with this finding, no improvement in glucose tolerance was observed during an intraperitoneal glucose tolerance test in C57BL6 mice that were administered a subcutaneous dose of PF-06882961 (10 mg/kg) (Fig
Platform Our proprietary platform connects artificially intelligent antibody design to functional DSIP neutralization